Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Arethusa de Souza"'
Autor:
Guilherme Rossi Assis-Mendonça, Maria Carolina Pedro Athié, João Vitor Gerdulli Tamanini, Arethusa de Souza, Gabriel Gerardini Zanetti, Patrícia Aline Oliveira Ribeiro de Aguiar Araújo, Enrico Ghizoni, Helder Tedeschi, Marina Koutsodontis Machado Alvim, Vanessa Simão de Almeida, Welliton de Souza, Roland Coras, Clarissa Lin Yasuda, Ingmar Blümcke, André Schwambach Vieira, Fernando Cendes, Iscia Lopes-Cendes, Fabio Rogerio
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionFocal cortical dysplasia (FCD) is a common cause of pharmacoresistant epilepsy. According to the 2022 International League Against Epilepsy classification, FCD type II is characterized by dysmorphic neurons (IIa and IIb) and may be associ
Externí odkaz:
https://doaj.org/article/07962596e794421e970f3a49e21d22fa
Autor:
Guilherme Rossi Assis-Mendonça, Maria Carolina Pedro Athié, João Vitor Gerdulli Tamanini, Arethusa de Souza, Gabriel Gerardini Zanetti, Patrícia Aline Oliveira Ribeiro de Aguiar Araújo, Enrico Ghizoni, Helder Tedeschi, Marina Koutsodontis Machado Alvim, Vanessa Simão de Almeida, Welliton de Souza, Roland Coras, Clarissa Lin Yasuda, Ingmar Blümcke, André Schwambach Vieira, Fernando Cendes, Iscia Lopes-Cendes, Fabio Rogerio
Focal cortical dysplasia (FCD) is a common cause of pharmacoresistant epilepsy. According to the 2022 International League Against Epilepsy classification, FCD type II is characterized by dysmorphic neurons (IIa and IIb) and may be associated with ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72493e3fb8d930ab0b573318bbde476b
https://doi.org/10.1101/2022.08.23.22279011
https://doi.org/10.1101/2022.08.23.22279011